Allscripts hosts Developer Challenge: Advancing Health Equity Using Social Determinants of Health
August 18 2021 - 08:01AM
Business Wire
Developer organizations share solutions with
Allscripts to solve unique challenges in serving diverse patient
populations
Allscripts (NASDAQ: MDRX) recently hosted its Advancing Health
Equity Using Social Determinants of Health Developer Challenge in
an effort to elevate solutions that use technology to share
relevant social determinants of health patient information with
care providers. Access to patients’ social determinants of health
(SDOH) information is crucial in advancing health equity across
patient populations—especially at a time when equitable access to
healthcare is more important than ever. The event included a
Keynote Fireside Chat with Dr. Micky Tripathi, the National
Coordinator for Health IT, who shared an update on efforts by ONC
and the Biden Administration more broadly to address the challenges
associated with health inequities.
Eight developer organizations were selected for the final round
of judging and had an opportunity to present their solution and
respond to questions related to topics such as integration and
workflow with existing Allscripts solutions, user input in the
design of the solution, specific benefits for underserved patient
populations and the ability of the solution to scale to a large
number of users. Allscripts recruited developer organizations to
help answer this question: “How can we use technology and
innovative solutions to share relevant patient SDOH information
with care providers to advance equity of healthcare access?”
The finalists presented a variety of solutions that will each
advance access to information that could impact patient care:
- Experian Health relies on consumer data assets, rather
than patient surveys, to identify at-risk patients and arm care
teams with actionable information around readmission risk and SDOH
that could impact patient care.
- Health Endeavors supports a care coordination tool and
online SDOH questionnaire to help deliver a comprehensive health
history that includes patient-generated data.
- MedAware presented a patient-specific risk estimate for
future dependency or overdose from a patient’s first opioid
prescription and throughout the duration of treatment, enabling
early intervention.
- Myelin Solutions is a care collaboration platform for
care teams to easily identify and close care gaps for their patient
population using a variety of data sources.
- PatientLink gives clinics the ability to capture SDOH
from patients using a variety of platforms, including paper and
digital forms from any device.
- Phreesia provides the ability to electronically screen
patients for SDOH risk factors across a variety of domains,
utilizing either customized screening questions or standardized
screening tools.
- Welfie is a health equity platform that enables families
to build a health profile by connecting their data and completing
health assessments.
The challenge winner, Patient Orator, has created an easy way
for patients and providers to address bias and health inequities by
bridging the communication gap between patients and their health
teams and facilitating meaningful conversations using technology.
Its team of experts has standardized how patients identify their
health concerns, care preferences, and social needs through its
HIPAA-compliant mobile app. The organization is also aligning
high-risk individuals with unmet socioeconomic and medical needs to
social care organizations and healthcare providers to improve
patient and community engagement, leveraging technology to improve
health outcomes.
“Patient Orator was created by underserved people for
underserved communities and is designed to make it easier for
historically marginalized groups to gain access to needed resources
and to help empower the voices of the unheard,” said Kistein
Monkhouse, MPA, Founder and Chief Executive Officer of Patient
Orator. “We are so grateful that Allscripts acknowledges how
important advancing health equity is and want to thank the company
for the opportunity to share our solutions with care providers
across the continuum of care.”
“Through this initiative, we are giving clinicians an
opportunity to have more meaningful interactions with patients that
enable them to address the important aspects of the patient’s daily
life that could make a difference in their overall health. We’re
looking forward to working with the Patient Orator team and helping
to enable this solution for Allscripts clients,” said Tina Joros,
Allscripts Vice President and General Manager of the Open Business
Unit and Practice Management Solutions. “I’m inspired to think
about the enormous potential for good that we can do when we bring
the information we gained from this challenge to the point of
care.”
About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information
technology solutions that advance clinical, financial, and
operational results. Our innovative solutions connect people,
places and data across an Open, Connected Community of Health™.
Connectivity empowers caregivers and consumers to make more
informed decisions, delivering better care for healthier
populations. To learn more, visit www.allscripts.com, Twitter,
YouTube and It Takes A Community: The Allscripts Blog.
© 2021 Allscripts Healthcare, LLC and/or its affiliates. All
Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are
trademarks of Allscripts Healthcare, LLC and/or its affiliates. All
other products are trademarks of their respective holders, all
rights reserved. Reference to these products is not intended to
imply affiliation with or sponsorship of Allscripts Healthcare, LLC
and/or its affiliates.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210818005183/en/
Investors: Stephen Shulstein
312-386-6735 Stephen.Shulstein@allscripts.com
Media: Concetta Rasiarmos
312-447-2466 concetta.rasiarmos@allscripts.com
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Veradigm (NASDAQ:MDRX)
Historical Stock Chart
From Mar 2023 to Mar 2024